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Abstract:  
Introduction: The underlying problem for two 
of the three most common patterns of 
unexpected hospital deaths (PUHD) is 
hypoventilation1. Concern over this opioid-
induced respiratory depression has led many 
experts and consensus guidelines to 
recommend that all patients receiving 
opioids be monitored for respiration. We 
propose an additional metric, ataxic 
breathing severity, be monitored in patients 
receiving opioids. Methods: With IRB 
approval, data were collected from 26 
volunteers who were administered target 
controlled infusions of remifentanil and 
propofol in order to induce low respiratory 
rates. Data were collected from a suite of 
sensors which were analyzed using a single, 
custom breath detection algorithm.  Three 
domain experts rated the data according to 
degree of irregularity, or ataxia, in the 
respiratory waveform. A machine learning 
algorithm was then trained to reproduce 
those results.  Results: Interrater reliability 
analysis confirmed that a machine learning 
algorithm was capable of mimicking scores 
from domain experts with a high degree of 
accuracy. Conclusion: Detecting ataxic, or 
irregular, respiratory rate is possible using an 
automated detection system.   
 
INTRODUCTION & BACKGROUND 
Respiratory depression is the most likely 
mechanism underlying the high morbidity 
and mortality rates associated with opioid 
use, both legitimate and illicit2-4. A recent  
 
analysis of the Anesthesia Closed Claims 
Project database found that in 92 respiratory 
depression related cases, “the vast majority 
of events occurred within 24 hours of surgery 
and 97% were preventable with better 
monitoring and response” 4. 
These problems would be especially 
troublesome during long-range, manned 
space missions where monitoring personnel 
are limited due to either sedation of crew 
members or an injury rendering the crew 
short-handed. 
Respiratory depression is caused by drug-
induced inhibition of the breathing control 
center of the brain stem. Partial to full airway 
obstruction is an anatomic problem involving 
the soft palate, tongue base, and/or 
epiglottis, caused by drug-induced 
decreases in airway patency and muscle 
tone. Sedatives and opioids depress the 
response to elevated CO2 (reduced drive to 
breathe), worsen arousal, cause airway 
obstruction, and change sleep patterns6-10 
These adverse respiratory effects often 
appear quickly following opioid 
administration, and may lead to adverse 
problems such as central and obstructive 
apneas/hypopneas, ataxic breathing and 
hypoxemia, which frequently develop without 
underlying cardiopulmonary disease3.   
Monitoring for these effects in the 
perioperative period typically includes 
measurement of arterial oxygen saturation 
by pulse oximetry (SpO2), respiratory rate,  
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end-tidal carbon dioxide (PetCO2.) by 
capnometry, and systematic sedation 
assessments11-13. However, slow response 
time, high equipment costs, and unreliability 
of human factors limit the effectiveness of 
these monitoring methods, respectively13,14. 
As early as 1876, French physician Chamille 
Biot described a pattern of irregular, or 
ataxic, breathing depicted in figure 1. 
Although widely recognized as a 
manifestation of opioids’ toxic effects on the 
central respiratory pattern generator15, the 
degree of ataxic breathing is not routinely 
monitored, in part because ataxic breathing 
is not currently easy to quantify in real-time. 
A visual scoring template for rating ataxic 
breathing has been suggested, but requires 
considerable expertise and manual offline 
analysis16.  
We hypothesized that a machine learning 
algorithm could accurately reproduce expert 
consensus on ataxic breathing severity in 
patients receiving opioids.  
We suggest that monitoring for ataxic 
breathing could provide caretakers with 
critical information regarding the respiratory 
status of a patient, potentially in advance of 
life threatening adverse events.  
 
 
 
 
 
 
 
 
METHODS 
Informed written consent was obtained from 
26 volunteers (13 male, 13 female).  Eligible 
volunteers had an ASA physical status of I or 
II, age 18 to 55 years, body mass index 
between 18 and 30 kg/m2, negative drug 
screen, and uncomplicated airway anatomy. 
Volunteers were not eligible if they had a 
history of significant alcohol or drug abuse, a 
positive drug-screening test, allergy to 
opioids or propofol, obstructive sleep apnea, 
any prescription medication intake other than 
oral contraceptives in the 48 hours preceding 
the study, or medical illnesses that are 
known to alter the pharmacokinetics or 
pharmacodynamics of opioids or intravenous 
anesthetics. 
Volunteer subjects were instrumented with a 
three lead electrocardiogram that detects 
respiratory rate using chest impedance 
(Datex Ohmeda, GE Healthcare, Helsinki, 
Finland), a photo-plethysmography (PPG) 
sensor (SET, Masimo Corporation, Irvine, 
CA), an abdominal accelerometer sensor 
(ADXL345, Analog Devices, Norwood, MA),  
respiratory inductance plethysmography 
(RIP) chest bands (Q-RIP, Braebon Medical 
Corporation, Kanata, ON, Canada), a 
capnometer nasal cannula (LoFlo, Philips 
Medical, Wallingford CT), a nasal airway 
pressure sensor (1 INCH-D-4V, All Sensors, 
Morgan Hill, CA), a nasal/oral thermistor 
(Disposable Adult Airflow Sensor, Braebon 
Figure 1: Biot’s “ataxic” breathing in a 16 year old male with tuberculosis meningitis. The 
waveforms depict an irregular respiration pattern from a spirometer.  
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Medical Corporation, Kanata, ON, Canada), 
and a peri-tracheal microphone (Audio-
Technica ATR3350iS. Machida, Tokio, 
Japan) positioned within a metal pre-cordial 
stethoscope cup (Wenger #00-390-c, AINcA, 
San Marcos, CA) placed just below the 
larynx and above the suprasternal notch. 
Data waveforms were digitized at 100 Hz 
with the exception of the acoustic waveform 
which was digitized at 44.1 kHz.   The 
placement of these sensors is illustrated in 
figure 2.  
 
Figure 2: Placement of body sensors during 
study.  
 
A 20 gauge venous catheter was placed in 
an antecubital vein under local anesthesia 
(0.2 mL of 0.5% lidocaine) for the purpose of 
hydration and drug administration.  The IV 
site was similar in all subjects. A 
maintenance infusion of 0.9% sodium 
chloride was administered at 1 ml/kg/hour 
throughout the study. Continuous infusions 
of Remifentanil and Propofol was infused 
into this peripheral IV.  
Our team previously characterized various 
effects of sedatives combined with opioids 
using drug interaction models. Specifically, 
we characterized the interaction of Propofol 
and Remifentanil on metrics of airway 
obstruction and intolerable ventilatory 
depression in volunteers.10 Each subject 
received Propofol and Remifentanil. Similar 
to previously collected data from our 
volunteer laboratory (Kern et al, 2004), each 
drug was administered using a computer 
controlled (Stanpump13) continuous infusion 
pump (Pump 22; Harvard Apparatus, 
Limited, Holliston, MA) to achieve selected 
target effect site concentrations.  The effect 
site concentration refers to the drug 
concentration at the pharmacologic site of 
action. Pharmacokinetic parameters 
published by Minto et al.14 and Schnider et 
al.15 was used for Remifentanil and Propofol 
respectively. 
We administered Propofol and Remifentanil 
pairs in a dose escalation scheme with small 
steps in order to creep up to the desired 
target effects of respiratory depression, 
airway obstruction and both effects while 
avoiding overshoot. To accomplish this, the 
Propofol was dosed in a range of 0.75 - 4 
mcg/mL in dose escalation steps of 
approximately 0.5 mcg/mL. Remifentanil was 
dosed in a range of 0.75 to 4.0 ng/mL in 
escalation steps of approximately 0.25-0.5 
ng/mL.  
Data were isolated from periods during which 
the patient was unperturbed, not talking, and 
breathing normally (no obstruction present). 
A custom algorithm which detects peak 
prominence in each signal and compares it 
to predefined thresholds was used to detect 
breathing in each signal.  
Figure 2: Placement of body sensors during 
study.  
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The data were divided into sections 
containing thirty breaths each. In each 
section, all available sensors were plotted as 
waveforms to present to the domain experts. 
The three domain experts then individually 
rated each section for ataxic breathing 
severity according to a previously published 
visual scoring guideline. This guideline is 
presented in figure 3. The scoring guideline 
was digitized to 0 (no ataxia), 1 (mild ataxia), 
2 (moderate ataxia), 3 (severe ataxia), and 4 
(clustered breathing).  
 
 
 
 
 
 
 
 
 
 
 
The results from the raters were collected 
and then used to train a machine learning 
algorithm which used features based on 
interbreath interval variability and tidal 
volume variability to assess the degree of 
ataxic breathing in the data. In this case, the 
selected machine learning algorithm was a 
support vector machine using a fine 
guassian kernel function which was trained 
in Matlab. 
The machine then rated a subset (test set) of 
the data which it had previously not been 
exposed to. Interrator reliability analyses 
were used to determine the level of 
concordance between the algorithm and the 
domain experts. 
Specifically, Krippendorff’s Alpha and 
Vanbelle’s Kappa were used for this 
analaysis. Krippendorff’s Alpha is an 
interrator reliability tool which attempts to 
rate the amount of agreement among 
multiple raters. A score of 0 would indicate 
that the raters in the set did not agree above 
the level you would expect to happen by 
chance. A score of 1 indicates perfect 
agreement amongst all raters in the group. 
Vanbelle’s Kappa expands on this 
calculation by attempting to isolate a single 
rater, in this case the machine learning 
algorithm, and compare it against a set of 
raters. 
Confidence intervals on selected statistical 
variables were obtained by repeating the 
analysis 1000 times and selecting the 2.5 
and 97.5 quantiles of data. 
Support vector machines were trained on 
both RIP and nasal pressure based breath 
marks and tidal volumes.  
RESULTS 
A total of 219 30-breath segments of data fit 
the criteria described in the methods. On 
average, 100 of these segments were 
included in the machine learning training set 
and 119 were included in the machine 
learning testing set.  
Krippendorff’s alpha and Vanbelle’s kappa 
and their confidence intervals for each 
respective support vector machine are 
reported in table 1. 
 
Figure 3: Ataxic breathing severity guidelines 
published by Farney et al16.  
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DISCUSSION 
Current standards of respiratory monitoring 
are limited in their usefulness. As an 
example, pulse oximetry may take as many 
as 2-3 minutes to report a change in blood 
oxygenation following cessation of 
breathing. While a continuous respiratory 
monitor may alleviate this problem, 
respiratory rate alone has shortcomings. For 
example, the number of breaths in a given 
interval (usually 60 seconds, but sometimes 
less) tells you nothing about the respiratory 
pattern. As an example, see figure 4. In this 
figure, we see respiratory waveforms 
recorded over roughly one minute of 
respiration. During this period, roughly 12 
breath attempts can be seen which would 
normally be considered a healthy 
respiratory rate of 12 breaths per minute. 
However, we can also see that this patient 
experienced a long central apnea and 
potential airway obstruction indicated by the 
cessation in breathing and the out of phase 
RIP signals respectively.  
Based upon in vitro and in vivo animal 
models, the genesis of opioid-induced 
irregular respiratory rhythm appears to rest 
on the differential opioid sensitivity of two 
anatomically distinct but coupled rhythm 
generators located in the rostral  
 
 
 
ventrolateral medulla17-19. The pre-Bötzinger 
complex (preBötC) and the 
retrotrapezoid/parafacial respiratory group 
(RTN/pFRG) have been posited to be 
essential and sufficient for generation of 
respiratory rhythm17-19. Opiate sensitive 
neurons in the preBötC are active during 
inspiration while opiate insensitive neurons 
in the RTN/pFRG are active during 
expiration.  Application of u-opioid receptor 
agonists or neurotoxic lesioning of preBötC 
neurons expressing neurokinin-1 receptor, 
results in slowing of the respiratory rate and 
ultimately ataxic or quantal breathing20. The 
impact of opioid agonists on u-opioid 
receptors in the carotid body, which appears 
to modulate breath by breath variability, is 
unclear. The inter-breath interval is the 
primary regulated variable responsible for 
physiologic conditions that cause erratic 
breathing21. 
Despite widespread recognition that opioid 
induced ataxic breathing can be an indicator 
of opioid toxicity in patients receiving 
analgesic care, it is currently not monitored 
due to the lack of standards regarding its 
measurement.  
 
Rater Statistic 
RIP Band 
Mean (95% CI) 
Intranasal Pressure 
Mean (95% CI) 
Krippendorff's Alpha 
0.912 
(0.852 - 0.949) 
0.899 
(0.819 - 0.941) 
Vanbelle's Kappa 
0.970 
(0.951 - 0.983) 
0.961 
(0.921 - 0.979) 
Table 1: Interrater reliability statistics for each of the tested machine learning classifiers 
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The machine learning classifier created 
during this study was able to replicate 
domain expert’s opinion on ataxic breathing 
severity with a high degree of accuracy. 
Interestingly, it was able to do so regardless 
of the underlying sensor (RIP or nasal 
pressure) which was used to train the 
algorithm. This indicates any respiratory 
monitor with a sufficient degree of accuracy 
could be trained to detect ataxic breathing 
severity. 
It is our belief that an ataxic breathing 
severity score could add critical information 
when used in conjunction with standard 
respiration measures such as respiratory 
rate and blood oxygen saturation. The 
degree of breathing irregularity could be 
used as an indicator of opioids toxic effects 
on the brains respiratory pattern generators. 
This indication could be used to advise 
opioid dosing and further monitoring.  
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